The anti-inflammatory activity of clarithromycin inhibits TNFalpha production and prolongs survival following lipopolysaccharide administration in mice

Saved in:
Bibliographic Details
Published inInternational journal of antimicrobial agents Vol. 32; no. 2; pp. 195 - 196
Main Authors Tkalcević, Vanesa Ivetić, Bosnjak, Berislav, Pasalić, Ivanka, Hrvacić, Boska, Situm, Kristina, Kramarić, Miroslava Dominis, Glojnarić, Ines, Eraković Haber, Vesna
Format Journal Article
LanguageEnglish
Published Netherlands 01.08.2008
Subjects
Animals
Anti-Inflammatory Agents - pharmacology
Anti-Inflammatory Agents - therapeutic use
Clarithromycin - pharmacology
Clarithromycin - therapeutic use
Disease Models, Animal
Escherichia coli - metabolism
Escherichia coli Infections - drug therapy
Escherichia coli Infections - mortality
Humans
Lipopolysaccharides - administration & dosage
Mice
Mice, Inbred BALB C
Shock, Septic - drug therapy
Shock, Septic - mortality
Treatment Outcome
Tumor Necrosis Factor-alpha - antagonists & inhibitors
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:0924-8579
DOI:10.1016/j.ijantimicag.2008.03.016